Protein Kinase C-Delta Defect in Autoimmune Lymphoproliferative Syndrome-Like Disease: First Case from the National Iranian Registry and Review of the Literature

References

• Abolhassani H, Kiaee F, Tavakol M, Chavoshzadeh Z, Mahdaviani SA, Momen T, Yazdani R, Azizi G, Habibi S, Gharagozlou M, et al. 2018. Fourth update on the Iranian national registry of primary immunodeficiencies: integration of molecular diagnosis. J Clin Immunol. 38:816–32.
   PubMed Web of Science ®Google Scholar
• Abolhassani H, Tavakol M, Chavoshzadeh Z, Mahdaviani SA, Momen T, Yazdani R, Azizi G, Movahedi M, Hamidieh AA, Behniafard NJI, et al. 2019. National consensus on diagnosis and management guidelines for primary immunodeficiency. Immunology and Genetics Journal. 2:1–21.
   Google Scholar
• Alkhairy OK, Abolhassani H, Rezaei N, Fang M, Andersen KK, Chavoshzadeh Z, Mohammadzadeh I, El-Rajab MA, Massaad M, Chou J, et al. 2016. Spectrum of phenotypes associated with mutations in LRBA. J Clin Immunol. 36:33–45.
   PubMed Web of Science ®Google Scholar
• Alsultan A, Basher E, Alqanatish J, Mohammed R, Alfadhel M. 2018. Deficiency of ADA2 mimicking autoimmune lymphoproliferative syndrome in the absence of livedo reticularis and vasculitis. Pediatr Blood Cancer. 65.
   Web of Science ®Google Scholar
• Barzaghi F, Minniti F, Mauro M, Bortoli, M, Balter R, Bonetti E, Zaccaron A, Vitale V, Omrani M, Zoccolillo M, et al. 2018. ALPS-like phenotype caused by ADA2 deficiency rescued by allogeneic hematopoietic stem cell transplantation. Front Immunol. 9:2767.
   PubMed Web of Science ®Google Scholar
• Belot A, Kasher PR, Trotter EW, Foray AP, Debaud AL, Rice GI, Szynkiewicz M, Zabot MT, Rouvet I, Bhaskar SS, et al. 2013. Protein kinase cδ deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation. Arthritis Rheum. 65:2161–71.
   PubMed Web of Science ®Google Scholar
• Bousfiha A, Jeddane L, Picard C, Al-Herz W, Ailal F, Chatila T, Cunningham-Rundles C, Etzioni A, Franco JL, Holland SM, et al. 2020. Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification. J Clin Immunol. 40:66–81.
   PubMed Web of Science ®Google Scholar
• Cagdas D, Halacli SO, Tan C, LO B, Cetinkaya PG, Esenboga S, Karaatmaca B, Matthews H, Balci-hayati B, Arikoglu T, et al. 2019. A spectrum of clinical findings from ALPS to CVID: several novel LRBA defects. J Clin Immunol. 39: 726–738.
   Google Scholar
• Fang M, Abolhassani H, Lim CK, Zhang J, Hammarstrom L. 2016. Next generation sequencing data analysis in primary immunodeficiency disorders - future directions. J Clin Immunol. 36(Suppl 1):68–75.
   PubMedGoogle Scholar
• Fernandez-Medarde A, Santos E. 2011. Ras in cancer and developmental diseases. Genes & Cancer. 2:344–58.
   PubMedGoogle Scholar
• Gualco G, Vandenberg A, Koopmans S, Bacchi LM, Carneiro SS, Ruiz E, JR, Vecchi AP, Chan JK. 2008. Autoimmune lymphoproliferative syndrome in a patient with a new minimal deletion in the death domain of the FAS gene. Hum Pathol. 39: 137–41.
   Google Scholar
• Guo B, Su TT, Rawlings DJ. 2004. Protein kinase C family functions in B-cell activation. Curr Opin Immunol. 16:367–73.
   PubMed Web of Science ®Google Scholar
• Kiykim A, Ogulur I, Baris S, Salzer E, Karakoc-Aydiner E, Ozen AO, Garncarz W, Hirschmugl T, Krolo A, Yucelten AD, et al. 2015. Potentially beneficial effect of hydroxychloroquine in a patient with a novel mutation in protein kinase Cδ deficiency. J Clin Immunol. 35:523–26.
   PubMed Web of Science ®Google Scholar
• Kucuk ZY, Charbonnier, L-M., Mcmasters RL, Chatila T, Bleesing JJ. 2017. CTLA-4 haploinsufficiency in a patient with an autoimmune lymphoproliferative disorder. Journal of Allergy and Clinical Immunology. 140:862–64.e4.
   Google Scholar
• Kuehn HS, Niemela JE, Rangel-Santos A, Zhang M, Pittaluga S, Stoddard JL, Hussey AA, Evbuomwan MO, Priel DA, Kuhns DB, et al. 2013. Loss-of-function of the protein kinase C delta (PKCdelta) causes a B-cell lymphoproliferative syndrome in humans. Blood. 121:3117–25.
   PubMed Web of Science ®Google Scholar
• Limnander A, Depeille P, Freedman T, Liou J, Leitges M, Kurosaki T, Roose J, Weiss A. 2011. STIM1, PKC-δ and RasGRP set a threshold for proapoptotic Erk signaling during B cell development. Nat Immunol. 12:425–33.
   PubMed Web of Science ®Google Scholar
• Mao H, Yang W, Latour S, Yang J, Winter S, Zheng J, Ni K, Lv M, Liu C, Huang H, et al. 2018. RASGRP1 mutation in autoimmune lymphoproliferative syndrome-like disease. J Allergy Clin Immunol. 142:595–604.e16.
   Google Scholar
• Nabhani S, Schipp C, Miskin H, Levin C, Postovsky S, Dujovny T, Koren A, Harlev D, Bis AM, Auer F, et al. 2017. STAT3 gain-of-function mutations associated with autoimmune lymphoproliferative syndrome like disease deregulate lymphocyte apoptosis and can be targeted by BH3 mimetic compounds. Clin Immunol. 181:32–42.
   PubMed Web of Science ®Google Scholar
• Nimela JE, Lu L, Fleisher TA, Davis J, Caminha I, Natter M, Beer LA, Dowdell KC, Pittaluga S, Raffeld M, et al. 2011. Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis. Blood. 117:2883–6.
   PubMed Web of Science ®Google Scholar
• Oliveira JB. 2013. The expanding spectrum of the autoimmune lymphoproliferative syndromes. Curr Opin Pediatr. 25:722–29.
   PubMed Web of Science ®Google Scholar
• Oliveira JB, Bidere N, Niemela JE, Zheng L, Sakai K, Nix CP, Danner RL, Barb J, Munson PJ, Puck JM, et al. 2007. NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Proceedings of the National Academy of Sciences of the United States of America. 104:8953–58.
   PubMed Web of Science ®Google Scholar
• Oliveira JB, Bleesing JJ, Dianzani U, Fleisher TA, Jaffe ES, Lenardo MJ, Rieux-Laucat F, Siegel RM, SU HC, Teachey DT, et al. 2010. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH international workshop. Blood. 116:e35–e40.
   PubMed Web of Science ®Google Scholar
• Puck JM, Sneller MC. 1997. ALPS: an autoimmune human lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Semin Immunol. 9:77–84.
   PubMedGoogle Scholar
• Revel-vilk S, Fischer U, Keller B, Nabhani S, Gamez-diaz L, Rensing-ehl A, Gombert M, Honscheid A, Saleh H, Shaag A, et al. 2015. Autoimmune lymphoproliferative syndrome-like disease in patients with LRBA mutation. Clin Immunol. 159: 84–92.
   Google Scholar
• Salzer E, Santos-Valente E, Klaver S, Ban SA, Emminger W, Prengemann NK, Garncarz W, Mullauer L, Kain R, Boztug H, et al. 2013. B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C δ. Blood. 121:3112–16.
   PubMed Web of Science ®Google Scholar
• Schipp C, Schlutermann D, Honscheid A, Nabhani S, Holl J, Oommen PT, Ginzel S, Fleckenstein B, Stork B, Borkhardt A, et al. 2018. EBV negative lymphoma and autoimmune lymphoproliferative syndrome like phenotype extend the clinical spectrum of primary immunodeficiency caused by STK4 deficiency. Front Immunol. 9:2400
   PubMed Web of Science ®Google Scholar
• Seidel MG, KINDLE G, Gathmann B, Quinti I, Buckland M, Van Montfrans J, Scheible R, Rusch S, Gasteiger LM, Grimbacher B, et al.; Collaborators. 2019. The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol Pract. 7:1763–70.
   PubMed Web of Science ®Google Scholar
• Shiota M, Yang X, Kubokawa M, Morishima T, Tanaka K, Mikami M, Yoshida K, Kikuchi M, Izawa K, Nishikomori R, et al. 2015. Somatic mosaicism for a NRAS mutation associates with disparate clinical features in RAS-associated leukoproliferative disease: a report of two cases. J Clin Immunol. 35.
   Web of Science ®Google Scholar
• Takagi M, Ogata S, Ueno H, Yoshida K, Yeh T, Hoshino A, Piao J, Yamashita M, Nanya M, Okano T, et al. 2017. Haploinsufficiency of TNFAIP3 (A20) by germline mutation is involved in autoimmune lymphoproliferative syndrome. J Allergy Clin Immunol. 139:1914–22.
   PubMed Web of Science ®Google Scholar
• Takagi M, Shinoda K, Piao J, Mitsuiki N, Takagi M, Matsuda K, Muramatsu H, Doisaki S, Nagasawa M, Morio T, et al. 2011. Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation. Blood. 117:2887–90.
   PubMed Web of Science ®Google Scholar
• Westermann E, Grossi A, Fioredda F, Giardino S, Cappelli E, Terranova P, Palmisani E, Farmer J, Foldvari Z, Yamasaki Y, et al. 2017. Partial rag deficiency in a child with autoimmune cytopenia and features of autoimmune lymphoproliferative syndrome (ALPS). Journal of Clinical Immunology. 37:244–45.
   Web of Science ®Google Scholar